ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Aurobindo inks pact with Advent Pharmaceuticals for $12.5 million
November 14, 2018To acquire Australian pharma firm’s product -
M&As this week: PTC Therapeutics, Cambrex
July 30, 2018PTC Therapeutics has signed an agreement to acquire Agilis Biotherapeutics for $945m. -
PTC inks $200M Agilis takeover to snag late-phase gene therapy
July 26, 2018PTC Therapeutics is paying $200 million upfront to acquire Agilis Biotherapeutics. The deal gives PTC ownership of a gene therapy treatment for rare neurotransmitter disease AADC deficiency that is set to go before the FDA next year. -
PTC Therapeutics’ results in SMA has Biogen nervous
June 22, 2018Biogen currently has the only product on the market approved to treat spinal muscular atrophy (SMA), in Spinraza, and that treatment is pretty central to the biotech’s portfolio, bringing in $364 million in revenue in the first quarter.
Pharma Sources Insight January 2025
